The controlling shareholder in a company that is trying to develop a treatment for Covid-19 that does not involve vaccinations is Novak Djokovic.
The world's No 1 was deported from Australia this week after the government canceled his visa in a dispute over a medical exemption for his unvaccinated status.
Ivan Loncarevic confirmed the investment to the news agency. He told the Financial Times that he had not spoken to the tennis star since November and that he was not anti-vax.
After losing a legal challenge to overturn the cancellation of his visa by the country's immigration minister, Novak was forced to leave Australia on Sunday.
Loncarevic said that the company was working on a treatment, not a vaccine, and had about 11 researchers working in three countries. The company says on its website that it started working on a deactivation mechanism for Covid-19 in July 2020.
The French government ruled on Monday that all athletes will have to be vaccine free in order to attend and compete in sporting events, which may prevent Novak Djokovic from defending his French Open title in May.
Loncarevic said that the company expects to launch clinical trials in Britain this summer for a product that blocks the coronaviruses from infecting the human cell.
A request for comment was not immediately responded to by a spokesman for the man.
How the controversy unfolded is shown in the video.
All Rights Reserved © 2024
